Skip to main content

Study M865

Study name

Drivsholm N 2021

Title

Alterations in the kynurenine pathway of tryptophan metabolism are associated with depression in people living with HIV

Overall design

The aim of this study was to investigate possible associations between alterations in the kynurenine pathway of tryptophan metabolism and the presence of depression in a predominantly well-treated people living with HIV population. Depression was defined as a diagnosis of depression according to the Major Depression Inventory (2 or 3 core symptoms with a score >= 4 plus at least 2 minor symptoms with a score >= 3) and/or current use of antidepressive medications. A total of 909 people living with HIV were recruited, including 100 people with depression (HIV with depression group) and 809 without depression (HIV without depression group). Plasma samples were used for the quantification of tryptophan, kynurenine, quinolinic acid, and kynurenic acid concentrations using liquid chromatography-tandem mass spectrometry.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive symptom; Depressive symptom with comorbidity; Depressive symptom with comorbidity;

Criteria for depression

Major Depression Inventory (2 or 3 core symptoms with a score >= 4 plus at least 2 minor symptoms with a score >= 3) and/or current use of antidepressive medications

Sample size

909

Tissue

Peripheral; Blood; Plasma;

Platform

MS-based; LC-MS: not reported;

PMID

33633032

DOI

10.1097/QAI.0000000000002664

Citation

Drivsholm N, Knudsen AD, Faurholt-Jepsen M, et al. Alterations in the kynurenine pathway of tryptophan metabolism are associated with depression in people living with HIV. J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):e177-e181.

Metabolite

Quinolinic acid;

Kynurenic acid/Quinolinic acid ratio;